Home > Research > Publications & Outputs > The effect of the chemokine rhMIP-1 alpha, and ...
View graph of relations

The effect of the chemokine rhMIP-1 alpha, and a non-aggregating variant BB-10010, on blast cells from patients with acute myeloid leukaemia

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

The effect of the chemokine rhMIP-1 alpha, and a non-aggregating variant BB-10010, on blast cells from patients with acute myeloid leukaemia. / Owen-Lynch, P J; Adams, J A; Brereton, M L et al.
In: British Journal of Haematology, Vol. 95, No. 1, 10.1996, p. 77-84.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Owen-Lynch, PJ, Adams, JA, Brereton, ML, Czaplewski, LG, Whetton, AD & Yin, JA 1996, 'The effect of the chemokine rhMIP-1 alpha, and a non-aggregating variant BB-10010, on blast cells from patients with acute myeloid leukaemia', British Journal of Haematology, vol. 95, no. 1, pp. 77-84. https://doi.org/10.1046/j.1365-2141.1996.7312349.x

APA

Owen-Lynch, P. J., Adams, J. A., Brereton, M. L., Czaplewski, L. G., Whetton, A. D., & Yin, J. A. (1996). The effect of the chemokine rhMIP-1 alpha, and a non-aggregating variant BB-10010, on blast cells from patients with acute myeloid leukaemia. British Journal of Haematology, 95(1), 77-84. https://doi.org/10.1046/j.1365-2141.1996.7312349.x

Vancouver

Owen-Lynch PJ, Adams JA, Brereton ML, Czaplewski LG, Whetton AD, Yin JA. The effect of the chemokine rhMIP-1 alpha, and a non-aggregating variant BB-10010, on blast cells from patients with acute myeloid leukaemia. British Journal of Haematology. 1996 Oct;95(1):77-84. doi: 10.1046/j.1365-2141.1996.7312349.x

Author

Owen-Lynch, P J ; Adams, J A ; Brereton, M L et al. / The effect of the chemokine rhMIP-1 alpha, and a non-aggregating variant BB-10010, on blast cells from patients with acute myeloid leukaemia. In: British Journal of Haematology. 1996 ; Vol. 95, No. 1. pp. 77-84.

Bibtex

@article{c09a8f2644aa4bc799d5fae95dd50b2f,
title = "The effect of the chemokine rhMIP-1 alpha, and a non-aggregating variant BB-10010, on blast cells from patients with acute myeloid leukaemia",
abstract = "The effects of recombinant macrophage inflammatory protein 1 alpha (rhMIP-1 alpha) on the proliferation of leukaemic blast cells from patients with acute myeloid leukaemia was assessed. Using the previously described [3H]thymidine incorporation index assay, the response of autonomous and growth factor responsive AML blast cells to the chemokine rhMIP-1 alpha was measured. In the case of autonomous proliferators, rhMIP-1 alpha had no inhibitory effect on [3H]thymidine incorporation and in 4/6 cases [3H]-thymidine incorporation was stimulated by rhMIP-1 alpha. In the presence of stem cell factor (SCF), a majority (8/9) of the samples which responded to this growth factor were inhibited when rhMIP-1 alpha was included in the assay medium. Similar results were obtained with GM-CSF-responsive samples; however, when these two cytokines were combined, only 3/14 were significantly inhibited. In the presence of human placental conditioned medium (HPCM), rhMIP-1 alpha significantly inhibited [3H]thymidine incorporation in only 2/10 of HPCM-responsive samples. In methylcellulose assays rhMIP-1 alpha had no consistent effect on colony/cluster formation in the presence of either GM-CSF + SCF or HPCM. Similar results were obtained with BB-10010, a mutant of rhMIP-1 alpha which has defined aggregation properties in solution. These data suggest that autonomously proliferating AML cells, and also some AML samples which require cytokines to proliferate, are non-responsive to the growth inhibitors rhMIP-1 alpha and BB-10010 in the presence of multiple growth factors.",
keywords = "rhMIP-1α, BB-10010 , AML , proliferation , growth factors",
author = "Owen-Lynch, {P J} and Adams, {J A} and Brereton, {M L} and Czaplewski, {L G} and Whetton, {A D} and Yin, {J A}",
year = "1996",
month = oct,
doi = "10.1046/j.1365-2141.1996.7312349.x",
language = "English",
volume = "95",
pages = "77--84",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "1",

}

RIS

TY - JOUR

T1 - The effect of the chemokine rhMIP-1 alpha, and a non-aggregating variant BB-10010, on blast cells from patients with acute myeloid leukaemia

AU - Owen-Lynch, P J

AU - Adams, J A

AU - Brereton, M L

AU - Czaplewski, L G

AU - Whetton, A D

AU - Yin, J A

PY - 1996/10

Y1 - 1996/10

N2 - The effects of recombinant macrophage inflammatory protein 1 alpha (rhMIP-1 alpha) on the proliferation of leukaemic blast cells from patients with acute myeloid leukaemia was assessed. Using the previously described [3H]thymidine incorporation index assay, the response of autonomous and growth factor responsive AML blast cells to the chemokine rhMIP-1 alpha was measured. In the case of autonomous proliferators, rhMIP-1 alpha had no inhibitory effect on [3H]thymidine incorporation and in 4/6 cases [3H]-thymidine incorporation was stimulated by rhMIP-1 alpha. In the presence of stem cell factor (SCF), a majority (8/9) of the samples which responded to this growth factor were inhibited when rhMIP-1 alpha was included in the assay medium. Similar results were obtained with GM-CSF-responsive samples; however, when these two cytokines were combined, only 3/14 were significantly inhibited. In the presence of human placental conditioned medium (HPCM), rhMIP-1 alpha significantly inhibited [3H]thymidine incorporation in only 2/10 of HPCM-responsive samples. In methylcellulose assays rhMIP-1 alpha had no consistent effect on colony/cluster formation in the presence of either GM-CSF + SCF or HPCM. Similar results were obtained with BB-10010, a mutant of rhMIP-1 alpha which has defined aggregation properties in solution. These data suggest that autonomously proliferating AML cells, and also some AML samples which require cytokines to proliferate, are non-responsive to the growth inhibitors rhMIP-1 alpha and BB-10010 in the presence of multiple growth factors.

AB - The effects of recombinant macrophage inflammatory protein 1 alpha (rhMIP-1 alpha) on the proliferation of leukaemic blast cells from patients with acute myeloid leukaemia was assessed. Using the previously described [3H]thymidine incorporation index assay, the response of autonomous and growth factor responsive AML blast cells to the chemokine rhMIP-1 alpha was measured. In the case of autonomous proliferators, rhMIP-1 alpha had no inhibitory effect on [3H]thymidine incorporation and in 4/6 cases [3H]-thymidine incorporation was stimulated by rhMIP-1 alpha. In the presence of stem cell factor (SCF), a majority (8/9) of the samples which responded to this growth factor were inhibited when rhMIP-1 alpha was included in the assay medium. Similar results were obtained with GM-CSF-responsive samples; however, when these two cytokines were combined, only 3/14 were significantly inhibited. In the presence of human placental conditioned medium (HPCM), rhMIP-1 alpha significantly inhibited [3H]thymidine incorporation in only 2/10 of HPCM-responsive samples. In methylcellulose assays rhMIP-1 alpha had no consistent effect on colony/cluster formation in the presence of either GM-CSF + SCF or HPCM. Similar results were obtained with BB-10010, a mutant of rhMIP-1 alpha which has defined aggregation properties in solution. These data suggest that autonomously proliferating AML cells, and also some AML samples which require cytokines to proliferate, are non-responsive to the growth inhibitors rhMIP-1 alpha and BB-10010 in the presence of multiple growth factors.

KW - rhMIP-1α

KW - BB-10010

KW - AML

KW - proliferation

KW - growth factors

U2 - 10.1046/j.1365-2141.1996.7312349.x

DO - 10.1046/j.1365-2141.1996.7312349.x

M3 - Journal article

C2 - 8857942

VL - 95

SP - 77

EP - 84

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 1

ER -